Embed digital in your strategy
Simply translate your needs to generate evidence from pre-clinical to commercialization through a strong digital strategy, supported by a team of clinical and digital experts
The need for a digital-first approach
Clinical Research
Low R&D productivity is driven by lengthy clinical trial timelines, challenging recruitment, and increasing trial costs
Post-Market Surveillance
Continued reimbursement and regulatory approval requires complex, long-term real-world evidence to detect safety signals
Design innovative methods that will shape your evidence generation
Understanding complex conditions and generating meaningful real-world evidence can be hindered by reliance on subjective reporting and challenges in recruiting and retaining patients. Innovative technology can transform evidence generation by focusing on the most common symptoms and measuring progress in “millimeters, not meters” to unlock and deliver the therapies of the future. We help our clients clearly understand their challenges and identify opportunities where digital solutions can drive change to meet their goals.
Discover with Beats Medical how you can re-imagine evidence generation with digital solutions
01 Understand
Understand, through in-depth research, the current challenges, existing supports, and requirements where digital can drive change Deliverables:
- Research that aligns your team and stakeholders with current challenges
02 Decide
Decide the digital approach that will best meet your real-world evidence generation needs, while also engaging key stakeholders Deliverables:
- Business case – determine where technology will be a key driver for your evidence generation
03 Define
Define the digital journey, architecture, data models and product deployment plan that will become the cornerstone of your digital strategy Deliverables:
- Digital solution strategy – detailed digital product deployment roadmap including system architecture, data models, risk management documents
Define your digital strategy to enhance Clinical Research, recruitment, retention, and patients’ data collection
Define your digital strategy to enhance Post-Market Surveillance, ensuring compliance and reimbursement success
Our team of clinical and digital experts collaborating with you to define your strategy
Dr Ciara Clancy
Chief Executive Officer
Dr Clancy is a chartered physiotherapist and researcher who attained her PhD in Neurosurgery Outcomes from Trinity College, Dublin. Dr Clancy is passionate about advancing therapies and improving outcomes through digital innovation.
Andrew Phelan
Chief Operating Officer
Andrew Phelan’s background is in industry, having studied business and marketing at University and formerly worked with Intel. Andrew has spent the last 8 years shaping the DTx industry and leading the commercialization of our applied products globally.
Dr Wui-Mei Chew
Chief Medical Officer
Dr Wui-Mei is both a medical doctor and researcher with a Masters in Intermolecular Medicine. Wui Mei has always been passionate about providing the best evidence-based care to patients.
